101
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

The efficacy of parecoxib for pain control after hysterectomy: a meta-analysis of randomized controlled studies

, , &
Pages 3488-3495 | Received 28 Sep 2019, Accepted 24 Oct 2019, Published online: 06 Dec 2019
 

Abstract

Introduction

The efficacy of parecoxib for pain control after hysterectomy remains controversial. We conduct a systematic review and meta-analysis to explore the influence of parecoxib versus placebo on pain intensity after hysterectomy.

Methods

We search PubMed, Embase, Web of Science, EBSCO, and Cochrane Library databases through March 2019 for randomized controlled trials (RCTs) assessing the effect of parecoxib versus placebo on pain intensity after hysterectomy. This meta-analysis is performed using the random-effect model.

Results

Six RCTs are included in the meta-analysis. Overall, compared with control group after hysterectomy, parecoxib treatment is associated with substantially reduced pain scores in 4–6 h at rest (MD = −0.98; 95%CI = −1.14 to −0.81; p < .00001), pain scores in 12 h at rest (MD = −0.70; 95%CI = −0.77 to −0.63; p < .00001), pain scores in 12 h on sitting up (MD = −0.90; 95%CI = −1.03 to −0.77; p < .00001), pain scores in 24 h on sitting up (MD = −1.19; 95%CI = −1.94 to −0.44; p = .002), dose of analgesic need in parecoxib group is notably lower than that in control group (std. MD = −2.54; 95%CI = −3.97 to −1.10; p = .0005), but shows no obvious effect on pain scores in 24 h at rest (MD = −0.40; 95%CI = −1.47–0.67; p = .47), pain scores in 4–6 h on sitting up (MD = −0.54; 95%CI = −2.50–1.42; p = .59), first time to analgesic requirement between two groups (std. MD = −0.10; 95%CI = −0.47–0.26; p = .57), nausea or vomiting (RR = 0.92; 95%CI = 0.59–1.43; p = .70), and adverse events (RR = 0.86; 95%CI = 0.64–1.17; p = .34).

Conclusions

Parecoxib treatment provides additional benefits for pain control after hysterectomy.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.